Literature DB >> 6794083

Cardiovascular effect of imipramine and nortriptyline in elderly patients.

P Thayssen, M Bjerre, P Kragh-Sørensen, M Møller, O L Petersen, C B Kristensen, L F Gram.   

Abstract

Cardiovascular effects in elderly depressed patients (age 62-78 years) treated with imipramine (N = 11) or nortriptyline (N = 10) were recorded by monitoring of heart rate, blood pressure, systolic time intervals, standard ECG and 24-h ECG. The two drugs exhibited distinctly different cardiovascular reactions. The use of imipramine was severely limited by orthostatic hypotension occurring at subtherapeutic plasma levels, which resulted in falls with fracture in two patients. In contrast, nortriptyline at therapeutic drug levels did not significantly influence orthostatic blood pressure regulation. Nortriptyline caused moderate changes in systolic time intervals, indicating impairment in myocardial contractility. This effect was not seen with imipramine, but a majority of the patients did not reach therapeutic plasma levels because of blood pressure reactions. Neither imipramine nor nortriptyline induced changes in cardiac conduction time measurements or arrhythmias. In addition to the blood pressure reactions, the use of imipramine was complicated by dose dependent kinetics.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6794083     DOI: 10.1007/BF00432748

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  29 in total

1.  ECG changes during amitryptiline treatment.

Authors:  E B RASMUSSEN; P KRISTJANSEN
Journal:  Am J Psychiatry       Date:  1963-02       Impact factor: 18.112

2.  The hypotensive effect of imipramine hydrocloride in patients with cardiovascular disease.

Authors:  O F MULLER; N GOODMAN; S BELLET
Journal:  Clin Pharmacol Ther       Date:  1961 May-Jun       Impact factor: 6.875

3.  Steady-state kinetics of imipramine in patients.

Authors:  L F Gram; I Sondergaard; J Christiansen; G O Petersen; P Bech; N Reisby; I Ibsen; J Ortmann; A Nagy; S J Dencker; O Jacobsen; O Krautwald
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Dose-dependent kinetics of imipramine in elderly patients.

Authors:  M Bjerre; L F Gram; P Kragh-Sørensen; C B Kristensen; O L Pedersen; M Møller; P Thayssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.

Authors:  A Nagy; L Treiber
Journal:  J Pharm Pharmacol       Date:  1973-08       Impact factor: 3.765

7.  [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)].

Authors:  K H Kuck; P Hanrath; J Lubda; D Mathey; W Bleifeld
Journal:  Dtsch Med Wochenschr       Date:  1979-11-30       Impact factor: 0.628

8.  Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.

Authors:  P Kragh-Sorensen; C E Hansen; P C Baastrup; E F Hvidberg
Journal:  Psychopharmacologia       Date:  1976-02-02

9.  The cardiac effects of therapeutic plasma concentrations of imipramine.

Authors:  S J Kantor; A H Glassman; J T Bigger; J M Perel; E V Giardina
Journal:  Am J Psychiatry       Date:  1978-05       Impact factor: 18.112

10.  Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels.

Authors:  P Kragh-Sørensen; N E Larsen
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

View more
  15 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Adverse effects of antidepressants in the elderly.

Authors:  L Nolan; K O'Malley
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

3.  Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.

Authors:  M Jerling
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

4.  Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.

Authors:  S J Warrington; P Turner; B K Skrumsager
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

5.  Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients.

Authors:  P Christensen; H Y Thomsen; O L Pedersen; P Thayssen; H Oxhøj; P Kragh-Sørensen; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Dose-dependent kinetics of imipramine in elderly patients.

Authors:  M Bjerre; L F Gram; P Kragh-Sørensen; C B Kristensen; O L Pedersen; M Møller; P Thayssen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Overdosage of antidepressants: clinical and pharmacokinetic aspects.

Authors:  O L Pedersen; L F Gram; C B Kristensen; M Møller; P Thayssen; M Bjerre; P Kragh-SøRensen; N A Klitgaard; E Sindrup; P Hole; M Brinklø
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Dextropropoxyphene kinetics after single and repeated oral doses in man.

Authors:  K Brøsen; L F Gram; J Schou; N E Larsen; P Thayssen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Mianserin: cardiovascular effects in elderly patients.

Authors:  M Møller; P Thayssen; P Kragh-Sørensen; O L Pedersen; C B Kristensen; M Bjerre; S Benjaminsen; L F Gram
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 10.  Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.

Authors:  L L von Moltke; D J Greenblatt; R I Shader
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.